Extracorporeal Membrane Oxygenation (ECMO): Blood Cells

S

Spectrum Health Hospitals

Status

Completed

Conditions

Extracorporeal Membrane Oxygenation

Treatments

Other: Blood specimen collection

Study type

Observational

Funder types

Other

Identifiers

NCT02748668
2014-255

Details and patient eligibility

About

The objective of the study is to predict outcomes of patients on extracorporeal membrane oxygenation (ECMO) therapy by correlating cytokines and inflammatory cell patterns to clinical outcomes using data collected in the ECMO Registry at Spectrum Health.

Enrollment

371 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

ECMO group:

Inclusion Criteria:

  • Greater than or equal to 18 years of age
  • Subject presents to the CTICU at Butterworth Campus, Spectrum Health and is critically ill in the ICU needing ECMO therapy.

Exclusion Criteria:

  • Subject is less than 18 years of age
  • Known prisoner

Control Subjects:

Inclusion Criteria

  • Greater than 18 years of age
  • Without any known cardiovascular, lung, or autoimmune disease.

Exclusion Criteria:

  • Less than or equal to 18 years of age
  • Known cardiovascular, lung, or autoimmune disease

Trial design

371 participants in 2 patient groups

ECMO
Description:
No intervention. Blood specimen collection.
Treatment:
Other: Blood specimen collection
Control
Description:
No intervention. Blood specimen collection.
Treatment:
Other: Blood specimen collection

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems